First drug to target cause of Alzheimer's approved for use in Australia
A drug that's been found to slow the progress of Alzheimer's disease by clearing proteins in the brain has been approved for use in Australia. The Therapeutic Goods Administration (TGA) has approved a drug called Donanemab for those with mild …